Results 51 to 60 of about 20,467 (239)

Incidence of central involving macular oedema after cataract surgery in diabetic retinopathy patients – A prospective study

TNOA Journal of Ophthalmic Science and Research
Aim: To study the incidence of central macular oedema at 4, 8 and 12 weeks following cataract surgery in diabetic retinopathy eyes. Materials and Methods: A prospective observational study was conducted over a period of 3 months to investigate the ...
Sankari Alias Mansa Devi, V G Madhanagopalan   +1 more
doaj   +1 more source

Artificial intelligence using deep learning to screen for referable and vision-threatening diabetic retinopathy in Africa: a clinical validation study

The Lancet: Digital Health, 2019
Summary: Background: Radical measures are required to identify and reduce blindness due to diabetes to achieve the Sustainable Development Goals by 2030.
Valentina Bellemo, MSc, Zhan W Lim, PhD, Gilbert Lim, PhD, Quang D Nguyen, BEng, Yuchen Xie, MScPH, Michelle Y T Yip, BA, Haslina Hamzah, BSc, Jinyi Ho, DFST, Xin Q Lee, BSc (Hons), Wynne Hsu, PhD, Mong L Lee, PhD, Lillian Musonda, MD, Manju Chandran, FRCOphth, Grace Chipalo-Mutati, FCOphth (ECSA), Mulenga Muma, FCOphth (ECSA), Gavin S W Tan, MD, Sobha Sivaprasad, FRCOphth, Geeta Menon, FRCOphth, Tien Y Wong, MD, Daniel S W Ting, MD   +19 more
doaj   +1 more source

Fingolimod: therapeutic mechanisms and ocular adverse effects. [PDF]

, 2017
Fingolimod is an oral immunomodulating drug used in the management of relapsing-remitting multiple sclerosis (RRMS). We aim to review the published literature on ocular manifestations of fingolimod therapy and their possible underlying mechanisms.
A Groves, A Gupta, A Minuk, A Schwarz, AR Afshar, B Nealon, BJ McVerry, C Aguiar, D Ontaneda, G Saab, H Chen, H Tedesco-Silva, J Camm, J Chui, J Chun, JA Cohen, JA Cohen, JM Gelfand, K Schroder, K Turaka, L Kappos, L Kappos, L Liu, M Brar, M Salvadori, MA Zarbin, ML Oo, MT Bhatti, N Ueda, OJ Coppes, P A Keane, P Mandal, PA Calabresi, R Gallego-Pinazo, R Moosavi, RS Brush, S Thoo, V Li, VM Asensio-Sanchez, W Fusi-Rubiano, Y Yang   +40 more
core   +1 more source

Optical Coherence Tomography Angiography in Diabetic Patients: A Systematic Review

Biomedicines, 2021
Background: Diabetic retinopathy (DR) is the leading cause of legal blindness in the working population in developed countries. Optical coherence tomography (OCT) angiography (OCTA) has risen as an essential tool in the diagnosis and control of diabetic ...
Ana Boned-Murillo, Henar Albertos-Arranz, María Dolores Diaz-Barreda, Elvira Orduna-Hospital, Ana Sánchez-Cano, Antonio Ferreras, Nicolás Cuenca, Isabel Pinilla   +7 more
doaj   +1 more source

Aflibercept for the therapy of retinal diseases. A review of clinical studies

Российский офтальмологический журнал, 2018
Aflibercept is a hybrid protein-imitation of VEGF receptor with a prolonged activity. The review describes the structural properties of the Aflibercept molecule, the impact of the medication on the pathogenesis of retinal diseases, and the results of ...
T. D. Okhotsimskaya, O. V. Zaitseva
doaj   +1 more source

Intravitreal triamcinolone therapy for diabetic macular oedema [PDF]

British Journal of Ophthalmology, 2005
Which dosage should we use? It is less than 4 years ago since publication of the first report on the use of crystalline cortisone in the form of triamcinolone acetonide to treat recalcitrant macular oedema in patients with diabetes.1 This report of a single eye was rapidly followed by a case series from the same author (Jonas),2 who has remained ...
openaire   +2 more sources

Aptamer‐Based Delivery Systems for VEGF and NGF Modulation in Ocular Therapies

Advanced Healthcare Materials, EarlyView.
Aptamer‐based delivery systems targeting NGF and VEGF hold significant potential for precise and sustained treatment of complex diseases affecting both the anterior and posterior segments of the eye. This review critically summarizes current strategies for NGF and VEGF delivery as well as VEGF sequestration, providing a clinical perspective on how ...
Nadine Best, Gizem Karabiyik, Gerd Geerling, Sarah Barbara Zwingelberg, Gregor Lang, Martin Humenik   +5 more
wiley   +1 more source

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova, Yoana Lilova, Alexander Oscar, Alina Levi, Maria Kamusheva, Guenka Petrova   +5 more
wiley   +1 more source

Influence of glycaemic control on macular thickness in diabetic retinopathy

Endocrinology, Diabetes & Metabolism, 2022
Introduction Diabetic macular oedema (DME) is one of the major cause of decreased visual acuity in patients with diabetic retinopathy. Poor glycaemic control is associated with increased incidence of DME.
Sadhana Sharma, Pratap Karki, Sagun Narayan Joshi, Sanket Parajuli   +3 more
doaj   +1 more source

Retinopathy in old persons with and without diabetes mellitus: the Age, Gene/Environment Susceptibility--Reykjavik Study (AGES-R). [PDF]

, 2012
To access full text version of this article. Please click on the hyperlink "View/open" at the bottom of this pageWe aimed to describe the prevalence of retinopathy in an aged cohort of Icelanders with and without diabetes mellitus.
Aspelund, T, Benediktsson, R, Cotch, M F, Eiriksdottir, G, Gudnason, V, Gunnlaugsdottir, E, Halldorsdottir, S, Harris, T B, Jonasson, F, Klein, B E, Klein, R, Launer, L J   +11 more
core   +1 more source